Steven F Maier Selected Research

Hyperalgesia

1/2022	Suppression of active phase voluntary wheel running in male rats by unilateral chronic constriction injury: Enduring therapeutic effects of a brief treatment of morphine combined with TLR4 or P2X7 antagonists.
1/2021	Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain.
1/2019	A single peri-sciatic nerve administration of the adenosine 2A receptor agonist ATL313 produces long-lasting anti-allodynia and anti-inflammatory effects in male rats.
1/2018	MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats.
1/2018	Protraction of neuropathic pain by morphine is mediated by spinal damage associated molecular patterns (DAMPs) in male rats.
1/2018	DREADDed microglia in pain: Implications for spinal inflammatory signaling in male rats.
1/2018	Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists.
8/2017	Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia.
1/2017	Exploring acute-to-chronic neuropathic pain in rats after contusion spinal cord injury.
1/2017	Supradural inflammatory soup in awake and freely moving rats induces facial allodynia that is blocked by putative immune modulators.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven F Maier Research Topics

Disease

56	Pain (Aches) 10/2021 - 01/2003
54	Hyperalgesia 01/2022 - 12/2001
35	Neuralgia (Stump Neuralgia) 10/2022 - 02/2003
18	Shock 01/2021 - 01/2002
17	Infections 05/2018 - 02/2005
16	Inflammation (Inflammations) 01/2021 - 01/2004
11	Neuroinflammatory Diseases 10/2021 - 10/2011
6	Chronic Pain 11/2019 - 03/2005
4	Peripheral Nerve Injuries 01/2022 - 11/2008
4	Memory Disorders (Memory Loss) 01/2021 - 10/2004
4	Wounds and Injuries (Trauma) 01/2017 - 11/2012
4	Fever (Fevers) 10/2011 - 02/2003
4	Bacterial Infections (Bacterial Infection) 08/2011 - 04/2008
4	Opioid-Related Disorders (Opiate Addiction) 01/2010 - 02/2007
3	Contusions 01/2019 - 01/2017
3	Migraine Disorders (Migraine) 01/2017 - 01/2012
3	Escherichia coli Infections 01/2015 - 02/2010
3	AIDS-Related Complex (ARC) 08/2012 - 01/2010
3	Respiratory Insufficiency (Respiratory Failure) 01/2010 - 11/2008
2	Postoperative Cognitive Complications 01/2021 - 10/2012
2	Brain Diseases (Brain Disorder) 01/2021 - 05/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 01/2017
2	Hypersensitivity (Allergy) 11/2019 - 03/2015
2	Obesity 10/2017 - 11/2014
2	Mood Disorders (Mood Disorder) 01/2017 - 11/2003
2	Substance-Related Disorders (Drug Abuse) 01/2015 - 06/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2012 - 07/2007
2	Cognitive Dysfunction 06/2012 - 08/2011

Drug/Important Bio-Agent (IBA)

49	CytokinesIBA 01/2022 - 01/2003
22	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2002
18	Opioid Analgesics (Opioids)IBA 01/2021 - 12/2005
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
14	Toll-Like Receptor 4IBA 01/2021 - 07/2008
13	Interleukin-1 (Interleukin 1)IBA 08/2017 - 02/2003
11	Interleukin-10 (Interleukin 10)IBA 01/2019 - 03/2004
9	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 03/2004
9	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2018 - 10/2004
8	Messenger RNA (mRNA)IBA 01/2021 - 10/2004
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 02/2003
8	LipopolysaccharidesIBA 02/2015 - 08/2005
8	Interleukin-1beta (Interleukin 1 beta)IBA 11/2014 - 11/2003
8	Pharmaceutical PreparationsIBA 09/2011 - 12/2003
7	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 02/2002
7	Analgesics (Analgesic Drugs)IBA 09/2011 - 08/2004
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2012 - 08/2004
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 11/2007
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 11/2009
5	InflammasomesIBA 01/2018 - 08/2015
5	HMGB1 Protein (HMG1)IBA 01/2018 - 12/2003
5	Minocycline (Cyclops)FDA LinkGeneric 01/2017 - 05/2005
5	ChemokinesIBA 01/2017 - 08/2004
5	CorticosteroneIBA 10/2011 - 02/2003
4	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 07/2008
4	ATL 313IBA 01/2019 - 11/2009
4	salicylhydroxamic acid (SHAM)IBA 01/2019 - 11/2009
4	GlucocorticoidsIBA 11/2018 - 06/2011
4	Dinoprostone (PGE2)FDA Link 01/2017 - 01/2010
3	Neutralizing AntibodiesIBA 01/2019 - 03/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 03/2004
3	BradykininIBA 01/2017 - 01/2010
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 01/2010
3	ibudilastIBA 01/2017 - 02/2009
3	Ethanol (Ethyl Alcohol)IBA 08/2015 - 05/2013
3	Freund's AdjuvantIBA 02/2014 - 01/2012
3	Formaldehyde (Formol)FDA Link 02/2014 - 10/2010
3	Naloxone (Narcan)FDA LinkGeneric 05/2012 - 07/2008
3	Glycoproteins (Glycoprotein)IBA 01/2010 - 10/2005
2	Superoxides (Superoxide)IBA 10/2022 - 12/2016
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022 - 01/2017
2	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 11/2009
2	Toll-Like Receptor 2IBA 01/2021 - 05/2012
2	NLR ProteinsIBA 01/2019 - 01/2016
2	NF-kappa B (NF-kB)IBA 01/2019 - 10/2005
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 11/2007
2	LigandsIBA 01/2018 - 01/2017
2	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2018 - 11/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2016 - 03/2007
2	GlucuronidesIBA 02/2015 - 05/2013
2	morphine-3-glucuronideIBA 02/2015 - 05/2013
2	ethyl glucuronideIBA 02/2015 - 05/2013
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 12/2012 - 08/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2012 - 08/2010
2	Narcotic Antagonists (Opioid Antagonists)IBA 05/2012 - 07/2008
2	Glutamic Acid (Glutamate)FDA Link 09/2011 - 07/2004
2	AntibodiesIBA 08/2010 - 11/2009
2	DNA (Deoxyribonucleic Acid)IBA 07/2007 - 12/2006

Therapy/Procedure

16	Therapeutics 01/2022 - 07/2004
11	Analgesia 12/2016 - 08/2004
10	Spinal Injections 01/2018 - 03/2005
4	Laparotomy 01/2019 - 10/2010
3	Subcutaneous Injections 01/2012 - 03/2004
3	Injections 01/2012 - 12/2003
2	Behavior Control 06/2019 - 09/2012
2	Catheters 01/2017 - 01/2012
2	Pain Management 01/2016 - 04/2015
2	Ligation 10/2013 - 05/2012
2	Operative Surgical Procedures 01/2012 - 01/2004